Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Greg J. Divis currently holds 86,100 shares of AVADEL PHARMACEUTICALS PLC (AVDL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Greg J. Divis has been a net buyer of AVDL stock. They have purchased $292.3K and sold $0 worth of shares.
Greg J. Divis's most recent insider trade was on Nov 15, 2019, when they purchased 19,000 shares at $5.13 per share.
Greg J. Divis serves as Executive at AVADEL PHARMACEUTICALS PLC (AVDL). They have executed 7 insider transactions totaling $292.3K over their tenure at the company.
Greg J. Divis holds the position of Executive at AVADEL PHARMACEUTICALS PLC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Greg J. Divis has shown a buying trading pattern, with $292.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Greg J. Divis was on Sep 12, 2017, when they purchased $98.8K worth of AVDL shares. This transaction involved 10,600 shares at $9.32 per share.
Greg J. Divis currently owns 86,100 shares of AVADEL PHARMACEUTICALS PLC (AVDL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Greg J. Divis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Greg J. Divis has 7 Form 4 filings on record as an insider at AVADEL PHARMACEUTICALS PLC.
Set alerts for Greg J. Divis and 40,000+ other insiders.